An H Bui1,2, Sébastien Roujol2, Murilo Foppa2,3, Kraig V Kissinger4, Beth Goddu4, Thomas H Hauser2, Peter J Zimetbaum1,2, Long H Ngo2, Warren J Manning2,4, Reza Nezafat2, Francesca N Delling2,5. 1. Cardiovascular Division, Department of Medicine, Harvard-Thorndike Electrophysiology Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA. 2. Department of Medicine, Cardiovascular Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA. 3. Division of Cardiology, Hospital de Clinicas de Porto Alegre, Federal University of Rio Grande do Sul, Brazil. 4. Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA. 5. Department of Medicine, Division of Cardiology, University of California, San Francisco, California, USA.
Abstract
OBJECTIVE: We aimed to investigate the association of diffuse myocardial fibrosis by cardiac magnetic resonance (CMR) T1 with complex ventricular arrhythmia (ComVA) in mitral valve prolapse (MVP). METHODS: A retrospective analysis was performed on 41 consecutive patients with MVP referred for CMR between 2006 and 2011, and 31 healthy controls. Arrhythmia analysis was available in 23 patients with MVP with Holter/event monitors. Left ventricular (LV) septal T1 times were derived from Look-Locker sequences after administration of 0.2 mmol/kg gadopentetate dimeglumine. Late gadolinium enhancement (LGE) CMR images were available for all subjects. RESULTS: Patients with MVP had significantly shorter postcontrast T1 times when compared with controls (334±52 vs 363±58 ms; p=0.03) despite similar LV ejection fraction (LVEF) (63±7 vs 60±6%, p=0.10). In a multivariable analysis, LV end-diastolic volume, LVEF and mitral regurgitation fraction were all correlates of T1 times, with LVEF and LV end-diastolic volume being the strongest (p=0.005, p=0.008 and p=0.045, respectively; model adjusted R2=0.30). Patients with MVP with ComVA had significantly shorter postcontrast T1 times when compared with patients with MVP without ComVA (324 (296, 348) vs 354 (327, 376) ms; p=0.03) and only 5/14 (36%) had evidence of papillary muscle LGE. CONCLUSIONS: MVP may be associated with diffuse LV myocardial fibrosis as suggested by reduced postcontrast T1 times. Diffuse interstitial derangement is linked to subclinical systolic dysfunction, and may contribute to ComVA in MVP-related mitral regurgitation, even in the absence of focal fibrosis. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
OBJECTIVE: We aimed to investigate the association of diffuse myocardial fibrosis by cardiac magnetic resonance (CMR) T1 with complex ventricular arrhythmia (ComVA) in mitral valve prolapse (MVP). METHODS: A retrospective analysis was performed on 41 consecutive patients with MVP referred for CMR between 2006 and 2011, and 31 healthy controls. Arrhythmia analysis was available in 23 patients with MVP with Holter/event monitors. Left ventricular (LV) septal T1 times were derived from Look-Locker sequences after administration of 0.2 mmol/kg gadopentetate dimeglumine. Late gadolinium enhancement (LGE) CMR images were available for all subjects. RESULTS:Patients with MVP had significantly shorter postcontrast T1 times when compared with controls (334±52 vs 363±58 ms; p=0.03) despite similar LV ejection fraction (LVEF) (63±7 vs 60±6%, p=0.10). In a multivariable analysis, LV end-diastolic volume, LVEF and mitral regurgitation fraction were all correlates of T1 times, with LVEF and LV end-diastolic volume being the strongest (p=0.005, p=0.008 and p=0.045, respectively; model adjusted R2=0.30). Patients with MVP with ComVA had significantly shorter postcontrast T1 times when compared with patients with MVP without ComVA (324 (296, 348) vs 354 (327, 376) ms; p=0.03) and only 5/14 (36%) had evidence of papillary muscle LGE. CONCLUSIONS: MVP may be associated with diffuse LV myocardial fibrosis as suggested by reduced postcontrast T1 times. Diffuse interstitial derangement is linked to subclinical systolic dysfunction, and may contribute to ComVA in MVP-related mitral regurgitation, even in the absence of focal fibrosis. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Authors: F Grigioni; M Enriquez-Sarano; L H Ling; K R Bailey; J B Seward; A J Tajik; R L Frye Journal: J Am Coll Cardiol Date: 1999-12 Impact factor: 24.094
Authors: Benjamin T John; Balaji K Tamarappoo; Jack L Titus; William D Edwards; Win-K Shen; Sumeet S Chugh Journal: Heart Rhythm Date: 2004-07 Impact factor: 6.343
Authors: Yuchi Han; Dana C Peters; Carol J Salton; Dorota Bzymek; Reza Nezafat; Beth Goddu; Kraig V Kissinger; Peter J Zimetbaum; Warren J Manning; Susan B Yeon Journal: JACC Cardiovasc Imaging Date: 2008-05
Authors: Michael A Hagler; Thomas M Hadley; Heyu Zhang; Kashish Mehra; Carolyn M Roos; Hartzell V Schaff; Rakesh M Suri; Jordan D Miller Journal: Cardiovasc Res Date: 2013-04-03 Impact factor: 10.787
Authors: Leah Iles; Heinz Pfluger; Arintaya Phrommintikul; Joshi Cherayath; Pelin Aksit; Sandeep N Gupta; David M Kaye; Andrew J Taylor Journal: J Am Coll Cardiol Date: 2008-11-04 Impact factor: 24.094
Authors: Marco Gatti; Anna Palmisano; Antonio Esposito; Stefano Fiore; Caterina Beatrice Monti; Alessandro Andreis; Lorenzo Pistelli; Pasquale Vergara; Laura Bergamasco; Carla Giustetto; Francesco De Cobelli; Paolo Fonio; Riccardo Faletti Journal: Eur Radiol Date: 2021-04-19 Impact factor: 5.315
Authors: Andrea Sonaglioni; Gian Luigi Nicolosi; Michele Lombardo; Gian Franco Gensini; Giuseppe Ambrosio Journal: Int J Cardiovasc Imaging Date: 2020-10-30 Impact factor: 2.357
Authors: Paul J Marano; Lisa J Lim; Jose M Sanchez; Raza Alvi; Gregory Nah; Nitish Badhwar; Edward P Gerstenfeld; Zian H Tseng; Gregory M Marcus; Francesca N Delling Journal: J Interv Card Electrophysiol Date: 2020-06-06 Impact factor: 1.900
Authors: Simon Ermakov; Radhika Gulhar; Lisa Lim; Dwight Bibby; Qizhi Fang; Gregory Nah; Theodore P Abraham; Nelson B Schiller; Francesca N Delling Journal: Heart Date: 2019-02-12 Impact factor: 5.994